MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Video-based Machine Rating Model for MDS-UPDRS III in Parkinson’s disease: A Proof-of-concept Pilot Study

X. Zhu, Z. Chen, Y. Ling, K. Ren, Y. Tan, J. Liu (Shanghai, China)

Meeting: 2024 International Congress

Abstract Number: 1204

Keywords: Parkinson’s, Scales

Category: Technology

Objective: To develop a video-based machine rating system for the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III.

Background: MDS-UPDRS III is an essential evaluation scale of motor symptoms for Parkinson’s disease (PD) patients. Manual rating of the scale is time-consuming and subjective and might be solved by machine rating. Previous studies have made remarkable achievements, but rating the entire spectrum of MDS-UPDRS III through video has never been achieved, which largely compromises its application in clinical use. Five ratings for “Rigidity” and one rating for “Postural Stability” of the MDS-UPDRS III requiring physical contact between the physician and the patient cannot be performed in machine vision. Our team previously managed to construct models for rigidity evaluation based on features collected from patients’ motions through machine vision, which makes machine rating of the entire MDS-UPDRS III possible [1].

Method: Features from 2,610 videos of 149 PD patients were collected for Extreme Gradient Boosting machine learning. Four indirect Subitem models, 18 direct Subitem models, 4 SubScale score models, and 1 Total score model were constructed [figure 1, figure 2].

Results: This machine rating system achieved a 95% accuracy rate in the majority (77.8%) of Subitems under clinically accepted standards. Eleven Subitem Rating Models (50%) achieved intraclass correlation coefficients (ICCs) greater than 0.75 (excellent) [table 1]. Seven Subitem Rating Models (32.8%) exhibited ICCs between 0.60 and 0.74 (good). The models for the SubScale scores (r (Pearson correlation coefficient) ≥0.83, mean absolute error (MAE)≤2.18, ICC>0.69) and the Total score (r=0.93, MAE=3.98, ICC=0.91) all performed well [table 2].

Conclusion: All models showed consistency with expert ratings. Video-based features were demonstrated to be more informative, and machine rating of MDS-UPDRS III is possible. Multicenter studies are needed for validation.

Figure 1

Figure 1

Figure 2

Figure 2

Table 1

Table 1

Table 2

Table 2

References: [1] Zhu X, Shi W, Ling Y, Luo N, Yin Q, Zhang Y, et al. Contactless evaluation of rigidity in Parkinson’s disease by machine vision and machine learning. Chin Med J 2023;136:2254–2256. doi: 10.1097/CM9.0000000000002668.

To cite this abstract in AMA style:

X. Zhu, Z. Chen, Y. Ling, K. Ren, Y. Tan, J. Liu. Video-based Machine Rating Model for MDS-UPDRS III in Parkinson’s disease: A Proof-of-concept Pilot Study [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/video-based-machine-rating-model-for-mds-updrs-iii-in-parkinsons-disease-a-proof-of-concept-pilot-study/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/video-based-machine-rating-model-for-mds-updrs-iii-in-parkinsons-disease-a-proof-of-concept-pilot-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley